Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

IMPORTANCE: The EGFR inhibitors (EGFR-I) cetuximab and panitumumab and the angiogenesis inhibitors (AIs) bevacizumab and aflibercept have demonstrated varying efficacy in mCRC. OBJECTIVE: To document the overall impact of specific chemotherapy regimens on the efficacy of targeted agents in treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, David L., Pavlakis, Nick, Shapiro, Jeremy, Price, Timothy J., Karapetis, Christos S., Tebbutt, Niall C., Segelov, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537274/
https://www.ncbi.nlm.nih.gov/pubmed/26275292
http://dx.doi.org/10.1371/journal.pone.0135599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537274/
https://www.ncbi.nlm.nih.gov/pubmed/26275292
http://dx.doi.org/10.1371/journal.pone.0135599

Ejemplares similares